Published in:
01-02-2019 | Editorial
Providing Evidence: Step by Step—a Letter from Associate Editor, Tobias Else, MD
Author:
Tobias Else
Published in:
Discover Oncology
|
Issue 1/2019
Login to get access
Excerpt
Most endocrine tumors represent rare diseases and this is definitely true for pheochromocytoma, paraganglioma, and adrenocortical carcinoma. Even for the few endocrine tumors that are not rare, specific subtypes (e.g., anaplastic thyroid cancer) or the predisposing syndromes (e.g., multiple endocrine neoplasia type 1, von Hippel–Lindau disease) are certainly rare. The rarity of these diseases inherently challenges our ability to do impactful research, publish findings with broad application, and develop guidelines to provide evidence-based clinical care. …